Introduction
The identification of eosinophils and subsequent discussions of eosinophil-associated activities are invariably linked with the prominent groups of proteins stored in the numerous secondary granules contained within the cytoplasm of these leukocytes. 1, 2 Three abundant groups of proteins exist among the numerous proteins stored in secondary granules (reviewed by Lee et al 3 ) , including eosinophil major basic proteins (human and mouse: MBP-1 and MBP-2 4-7 ), eosinophil-associated ribonucleases (human: eosinophil-derived neurotoxin 8 and eosinophil cationic protein, 9 mouse: eosinophil-associated ribonucleases [Ear-1, -2, -6/7, -5/11 10, 11 ]), and eosinophil peroxidase (human and mouse: EPX 12, 13 ). The majority of the proteins stored in the secondary granules of eosinophils (by mass) is easily accounted for by MBP-1 and EPX, comprising ;50% and ;25%, respectively. 14, 15 However, despite their abundance and their relative effects on the morphology of the secondary granules, 16, 17 studies defining specific roles for these proteins in hematopoiesis and/or as mediators of eosinophil effector function in vivo remain inconclusive. Specifically, mice deficient for either MBP-1 16 or EPX 17 showed no hematopoietic perturbations at baseline, and effects on the pathologies linked to eosinophilassociated diseases remain controversial. [18] [19] [20] [21] The formation of eosinophils occurs during a 3-to 4-day process of proliferation and differentiation within the hematopoietic compartment from initially pluripotent stem cells that yield eosinophil lineagecommitted progenitor (EoP) cells. 22 An early period of granulopoiesis in EoPs is a hallmark event characterized by robust expression of the genes encoding a multitude of granule proteins (reviewed by Wintrobe et al 23 ). The granules containing MBP-1 and EPX themselves appear to form as small unit vesicles at the Golgi complex, which aggregate to form larger structures the sizes of which are multiples of this unit granule. 24, 25 Thus, expression of MBP-1 and EPX, as well as the formation of eosinophil secondary granules, is hypothesized to be a consequence of events in leukocytes whose lineage commitment toward the eosinophil cell subtype is already established.
Our demonstration that the singular loss of either MBP-1 or EPX in gene knockout mice (MBP-1 2/2 or EPX 2/2 , respectively) had no impact on the pulmonary pathologies linked with allergen provocation 16, 17 led us to hypothesize that the contributions of these granule proteins to disease pathology may occur via their combined activities. Thus, our intent was to cross the MBP-1 2/2 and EPX ). All mice were maintained in ventilated microisolator cages housed in a specific pathogen-free animal facility. Protocols and studies involving animals were performed in accordance with National Institutes of Health and Mayo Clinic Institutional Animal Care and Use Committee.
Hematologic assays: cytospins/smear preparations and cell counts/differentials Films (blood), brush smears (marrow and spleen), or cytospins (marrow progenitor cell cultures) were stained with Diff-Quik Stain Set (Siemens Healthcare Diagnostics, Newark, DE). Summaries and full descriptions of the hematologic methods noted above are outlined in detail in McGarry et al. 29 
Flow cytometry analysis
Single-cell suspensions were stained for 25 minutes on ice with cell type-specific antibodies after blockade of Fc receptors by using 1 mg/mL of Fc blocker (CD16/32; BD Biosciences). The cell surface definitions of various leukocyte populations described here include basophils (as described previously by Obata progenitor, and common myeloid progenitor cells were identified as described previously by Iwasaki et al 31 and de Bruin et al. 32 In summary, the lineage cocktail used to exclude other cells and to identify these progenitors included antibodies (eBioscience) specific for CD3 (145-2C11), CD4 (GK1.5), CD8a (53-6.7), B220 (RA3-6B2), CD19 (1D3), Gr1 (RB6-8C5), and Ter119 (Ly7d). Additional antibodies used included Sca1-PE-Cy7 (D7; eBioscience), CD34-FITC (RAM34; eBioscience), CD16/32-eFluor 450 (93; eBioscience), c-kit-APC (2B8; eBioscience), and IL-5Ra-PE (T21; BD Biosciences). For assessments of chimerism, CD45.1-PE-Cy7 (A20; eBioscience) and CD45.2-PE (104; eBioscience) were used. Flow cytometry was performed on a cytofluorimeter (CyAn; Dako, Carpinteria, CA). Data acquisition and analysis were performed by using Summit version 4.3 software (Dako). 
Assessments of apoptosis

Transmission electron microscopy
Peripheral blood leukocytes were sorted for cells staining positive for IL-5Ra-FITC, Siglec-F-PE, Gr1-PE-Cy7, and CCR3-Alexa 647 (83103; BD Biosciences) on a cytofluorimeter (FACSAria; BD Biosciences) using FACSDiva Version 6.1.1 software (BD Biosciences). As described in earlier studies by Ochkur et al, 33 after flow cytometric sorting, eosinophils were fixed in Trump's fixative (1% glutaraldehyde, 4% formaldehyde, 0.1 M phosphate buffer; pH 7.2) prior to preparation for electron microscopy and photographic evaluations.
Immunohistochemical detection of tissue eosinophils
The presence of bone marrow-derived eosinophils was determined by immunohistochemistry by using a rat monoclonal antibody (mAb) (MT3-25.1.1) recognizing an epitope common to the eosinophil-associated ribonucleases sequestered in the secondary granules of eosinophil lineage-committed leukocytes. 34 Partial bone marrow engraftment Partial (;70%) bone marrow chimeras were generated by irradiating (3 Gy whole-body irradiation) 3-month-old wild-type C57BL/6J control mice prior to adoptive transfer of marrow derived from double knockout MBP-1 Ex vivo generation of eosinophils by targeted proliferation/ differentiation of unselected bone marrow progenitors
The targeted differentiation and proliferation of eosinophil lineagecommitted cells ex vivo was achieved by using a marrow culture system 35 with modifications that have been previously described. 36 Briefly, whole marrow was flushed from tibias and femurs into supplemented RPMI, 35 red blood cells were lysed, and the suspension was resuspended at 10 6 cells/mL in RPMI further supplemented with 100 ng/mL stem cell factor and FLT3 ligand. Then, 12.5 3 10 6 marrow leukocytes were transferred to a 25-cm 2 culture flask and cultured until day 4, at which point the cells were washed and resuspended in RPMI supplemented with 10 ng/mL IL-5 and returned to culture. On days 8, 10, and 12 of culture, the cells were washed, and half the media was replaced with fresh media supplemented with 20 ng/mL IL-5.
Statistical analysis
Data were analyzed and graphed by using the GraphPad Prism statistics program (GraphPad Prism Software, San Diego, CA). Results are presented as means 6 standard error of the mean. Statistical analysis was performed by using Student t tests, with differences between means considered significant at P , .05.
Results
The concomitant loss of MBP-1 and EPX in double knockout mice results in a significant loss of peripheral eosinophils, creating an effectively eosinophil-deficient strain of mice 
/EPX
2/2 mice were deficient for peripheral blood eosinophils to an extent comparable to previously established eosinophil-deficient mouse strains such as DdblGATA 37 and PHIL. 27 This observation was confirmed by flow cytometric assessments of peripheral blood ( Figure 2B ) that used a mouse eosinophil-specific cell surface profile (CCR3 1 , IL-5Ra 1 ). Similar reductions in eosinophils are also observed in lympho-hematopoietic compartments such as the spleen (supplemental Figure 1) . In contrast, the number of basophils in the bone marrow of MBP-1
/EPX 2/2 mice (defined by flow cytometric methods; supplemental Figure 2 ) was unchanged relative to the other experimental cohorts examined, including wild-type as well as MBP-1 2/2 and EPX 2/2 single knockout mice ( Figure 2C ).
Assessments of peripheral blood hematocrits from the different experimental cohorts (mean 6 standard error of the mean) also showed that the loss of MBP-1 and EPX in double knockout mice had no impact on erythrocyte levels (wild-type, 45.3% 6 0.3%; MBP-1 ). 16, 17 In contrast, the rare circulating MBP-1 2/2
2/2 eosinophils demonstrated that while secondary granule-like vesicles remain, the secondary granules of these cells have lost both the electron-dense cores and much of the visual densities of the electron-translucent matrices ( Figure 3 , lower panels). As noted, the genes encoding these abundant secondary granule proteins are located on different mouse chromosomes, facilitating the production of double knockout mice through selective breeding strategies of the single knockout strains of mice; offspring genotypes are subject to Mendelian inheritance patterns based on the genotype of the breeding dam and sire. Various polymerase chain reaction (PCR) primer combinations used to identify and confirm the genotype of individual mice are shown for each loci (P 1 -P 5 , MBP-1 and P 1 -P 4 , EPX).
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For personal use only. on October 22, 2017. by guest www.bloodjournal.org From protein gene knockout mice ( Figure 4A ). Interestingly, one can detect eosinophil lineage-committed cells in the bone marrow of MBP-1 2/2 /EPX 2/2 mice, unlike in PHIL mice in which the number of marrow eosinophils and progenitors was virtually zero. This reduction of (but not the complete absence of) marrow eosinophils was also confirmed by immunohistochemical staining of formalinfixed and paraffin-embedded sections of femurs using an eosinophilspecific rat mAb (Ear mAb) recognizing a shared epitope of the eosinophil-associated ribonuclease cluster ( Figure 4B ). Collectively, these marrow assessments suggested a specific and unique defect in eosinophilopoiesis that was likely limited to EoPs and not earlier myeloid lineage stem cells ( Figure 5A ). Subsequent flow cytometric assessments of various lineage-committed marrow progenitors 26, 27 (supplemental Figure 4) , confirmed that the definitive loss of progenitor cells was limited to EoPs because the numbers of common myeloid progenitors and granulocyte monocyte progenitors in the marrow of MBP-1 Figure 5B ). These data also confirmed the fractional character of EoP depletion in MBP-1 2/2 /EPX 2/2 mice relative to the more complete loss of progenitors observed in PHIL mice. Significantly, assessments of apoptosis ( Figure 5C ) demonstrated that the fractional character of EoP depletion in MBP-1
mice relative to the loss of EoPs in PHIL mice is reflected in fractional Flow cytometric analysis (supplemental Figure 2 ) of bone marrow-derived leukocytes demonstrated again that the loss of eosinophils in MBP-1 2/2 /EPX 2/2 mice, similar to PHIL mice, had no effect on basophil populations. *P , .05.
increases of apoptosis observed in these populations relative to wildtype animals (threefold and eightfold, respectively). This implicates that EoP survival is a key kinetic parameter responsible for the loss of eosinophils in MBP-1 28 would fail to promote the production and accumulation of eosinophils. This hypothesis was tested by examining eosinophils derived from femoral marrow in each experimental cohort using immunohistochemistry and an mAb directed against a shared epitope of the eosinophil-associated ribonucleases cluster (ie, Ear mAb). The photomicrographs in Figure 6A show that an overwhelming expansion of marrow eosinophil lineagecommitted cells occurred in the parental IL-5 transgenic line of mice (NJ.1638 28 ) as well as in compound transgenic/single knockout animals (ie, NJ.1638/MBP-1 2/2 and NJ.1638/EPX
2/2
). In contrast, the loss of both MBP-1 and EPX in transgenic double knockout mice (ie, NJ.1638/MBP-1
) resulted in a loss of two to three orders of magnitude of eosinophil lineage-committed cells in the bone marrow ( Figure 6A ). However, similar to marrow in MBP-1 2/2 /EPX Figure 6B ). Given the lack of observed effects on non-EoPs in the marrow of double knockout mice, it was not surprising that total bone marrow progenitor cultures from these animals displayed no kinetic or steady-state population differences relative to the wildtype progenitors prior to the application of recombinant IL-5 and the proliferation of EoPs. However, substantive differences were observed when eosinophilopoietic pressure (ie, exposure of the cells to IL-5-containing media) was applied to the cultures. Figure 7B . These evaluations showed that MBP-1 2/2 /EPX 2/2 progenitors colonize the marrow of chimeric wild-type recipients and contributed to noneosinophil leukocyte populations at levels identical to the levels observed following the transfer of wild-type marrow. In contrast, MBP-1 2/2 /EPX 2/2 donor marrow in these mixed chimeric studies was unable to generate peripheral blood eosinophils to the same level, displaying a .80% decrease relative to the contribution achievable with wild-type donor marrow ( Figure 7B ).
Discussion
The expression and storage of unique proteins in the secondary granules of eosinophils represents a defining characteristic of these leukocytes both in terms of cell lineage identification and proposed effector functions (reviewed by Lee et al 2 ). In particular, the release of these proteins and other mediators stored within the secondary granules of eosinophils (ie, degranulation) has been a highlighted activity that is almost universally linked with these granulocytes. 38 The underlying assumption has been that the expression of the genes encoding the abundant eosinophil secondary granule proteins was a consequence of eosinophil lineage commitment of previously pluripotent hematopoietic precursors (reviewed by Mori et al 22 ). Our previous demonstration that the only baseline consequence of losing either MBP-1 or EPX in single knockout mice is the generation of peripheral eosinophils devoid of the respective secondary granule protein 16, 17 is consistent with this assumption. In light of this perceived mechanism of lineage commitment followed by differentiation/ proliferation and cell-specific gene expression, we could not explain our observation that the combined loss of both MBP-1 and EPX gene expression resulted in the collapse of eosinophilopoiesis. This result suggested that granule protein gene expression and/or possibly the process of granule formation was not simply a passive consequence of cell lineage commitment but instead may have a larger hematopoietic role. The data demonstrated that the loss of showed that the EoP populations of both PHIL (n 5 3) and MBP-1 2/2 /EPX 2/2 (n 5 7) mice each displayed significant increases in apoptosis (eightfold and threefold increases, respectively) relative to wild-type (n 5 7). *P , .05; **P , .002.
both MBP-1 and EPX expression led directly to an increase in apoptosis among EoPs. This observation suggests that similar to the mechanism proposed for the loss of eosinophils in PHIL mice, 27 effects on the survival of EoPs in MBP-1 2/2 /EPX 2/2 mice are a principle kinetic regulator limiting the steady-state number of marrow EoPs and, in turn, peripheral eosinophils. The demonstration that this blockade of eosinophilopoiesis was a cell-autonomous event that occurred in vivo (ie, the continued absence of MBP-1 2/2 /EPX 2/2 eosinophils in wild-type double knockout bone marrow chimeras) as well as in ex vivo cultures of MBP-1 2/2 /EPX 2/2 marrow progenitors, ruled out two significant potential mechanisms. Namely, EoP survival is not the result of the release of MBP-1 and EPX by resident eosinophils in the marrow, 39 modifying or creating a hematopoietic niche as part of a positive autocrine feedback loop supporting progenitor survival. In addition, the demonstration that wild-type hematopoietic stem cells could not rescue eosinophilopoiesis from MBP-1 2/2 /EPX 2/2 progenitors eliminated the possibility that the combined loss of these granule proteins prevented (and/or abolished) the release of trans-acting soluble factors that support EoP survival. Two global mechanisms that potentially link EoP survival and the coexpression of MBP-1 and EPX are noteworthy. However, it is also of note that the available data only tangentially support many of these mechanisms. Nonetheless, the available data do provide important insights and a framework suggesting the likelihood and probable relevance of given mechanisms. 
/EPX
2/2 mice have granules is consistent with a direct link between granule formation and eosinophilopoiesis. In addition, the observed granules in double knockout mice appear to be structurally different relative to eosinophil granules from wild-type mice, which suggests that the formation of granules has been partially affected by the loss of MBP-1 and EPX. Collectively, these observations may explain the partial, as opposed to the complete, ablation of EoPs in double knockout mice. Unfortunately, despite the correlative data in support of this hypothesis, a direct link of granule formation and EoP cell survival remains to be established. Variation 2: Sequestration of a toxicant. In this hypothesis, the loss of MBP-1 and EPX expression in EoPs leads to either the aberrant secretion of toxic granule components or the aberrant trafficking of toxic granule components into the cytoplasm. Given the toxic character of many of the eosinophil granule proteins (reviewed in Lee and Lee 38 ), it is difficult to ignore or dismiss this mechanism. As noted earlier, MBP-1 2/2 /EPX 2/2 eosinophils do display abnormalities in granule structure. However, the data also showed that the defect induced by the loss of MBP-1 and EPX expression is a cell-autonomous event and thus the aberrant release of a granule toxicant (eg, Ears) is an unlikely cause for the loss of EoPs. In contrast, even if only a small fraction of granule components such as Ears are released into the cytoplasm, this may be sufficient to underlie the observed cell-autonomous defect in MBP-1 2/2 /EPX 2/2 mice. Clearly, further studies investigating the specific trafficking of these proteins into granules vs the cytoplasm will be required to resolve this possibility. Variation 3: Unfolded protein response. Neutrophils are an abundant granulocyte population that follow a path of differentiation with some similarity to that of eosinophils. Cases of primary neutropenia occur in humans at a rate of approximately 1 in 10 6 subjects, 40 and several mechanisms have been proposed to account for severe congenital neutropenia (SCN). Approximately half the observed SCN cases are linked to mutations in ELA2, the gene encoding the neutrophil granule protein elastase. 40 It has been hypothesized that ) each displayed a significant expansion in total cell number with a resulting compositional shift to .98% eosinophils, the marrow of PHIL and MBP-1 2/2 /EPX 2/2 mice failed to undergo this expansion.
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For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From these mutations lead to an unfolded protein response in the endoplasmic reticulum resulting in blockade of differentiation and proliferation of progenitor cells (reviewed in Klein et al 41 ). In addition, it is noteworthy that knock-in mice with single ELA2 mutations found in patients do not result in a baseline neutropenia in these animals. 42, 43 This implies that effects on multiple granule proteins may be required for this effect in neutrophils. However, to date we have not been able to show that the engineered MBP-1 and EPX loci 16, 17 actually generate truncated or aberrant polypeptides (our unpublished observations) and the suggestion that specific events need to coordinately happen in two genes limits the probability of this explanation.
The loss of concomitant MBP-1 and EPX expression in progenitors disrupts instructive gene regulatory mechanisms contributing to the continued appearance and/or survival of EoPs
The recent demonstration that micro RNAs (miRNAs) have potential effects on eosinophilopoiesis 44 and that the noncoding RNA EGO regulates the translation of several secondary granule proteins during eosinophil development 45 suggests the possibility that noncoding RNAs and/or one or more miRNAs critical for eosinophil development are encoded within the MBP-1 and EPX loci. The direct and straightforward character of these potential mechanisms for the deficiency of eosinophils in MBP-1 2/2 /EPX 2/2 mice promote them as attractive explanations. Unfortunately, detailed examinations of the sequences at each loci have failed to reveal the presence of noncoding RNAs (our unpublished observations) nor have searches of available miRNA databases (eg, www.miRBase.org) identified any occult miRNAs within the deleted regions of the MBP-1 or EPX knockout loci. Moreover, the likelihood of these explanations is severely dampened by the observation that the genetic manipulation of two loci (MBP-1 and EPX) is required. This suggests that while it is possible that the genetic manipulations of the MBP-1 and EPX genes during the generation of these knockout mice induced effects on the expression of small regulatory RNAs encoded at these loci, this possibility is an unlikely explanation for the loss of EoP cells in MBP-1 2/2 /EPX 2/2 mice.
The specific mechanism(s) responsible for the eosinophil deficiency in MBP-1 2/2 /EPX 2/2 mice remains elusive; nonetheless, these animals have immediate value to the research community as a specific and targeted eosinophil-less mouse model. Relative to other strains of eosinophil-less mice (ie, PHIL 27 and DdblGATA 37 ), the specific genetic aberrations associated with the MBP-1 2/2 / EPX 2/2 genotype appear to elicit a targeted deletion of the eosinophil lineage with fewer logistical caveats that would limit the usefulness of this mouse model. For example, PHIL mice employ a cytocidal mechanism (ie, eosinophil-specific expression of a diphtheria toxin subunit); thus, it has been suggested that the presence of this diphtheria toxin-mediated killing may contribute to baseline inflammation in this mouse relative to wild-type mice. 46 The eosinophil-deficient character of DdblGATA mice results from a targeted mutation of a high-affinity GATA transcription factor binding site within the GATA-1 promoter itself. However, activities of GATA-1 are not confined to eosinophils 37 (reviewed by Ferreira et al 47 ) , and this mutation has been shown to have additional unintended consequences as demonstrated by perturbations observed in red cell numbers. 37 Our assessments of MBP-1
mice showed that neither of these issues appear to be relevant; total leukocyte counts (aside from eosinophils) are normal in these mice, and no other cell lineage (aside from eosinophils) appears to be affected. Thus, while future studies are necessary to understand the link between granule protein gene expression and the survival of committed progenitors, the resulting eosinophil-deficient mouse model will be helpful in gaining a better understanding of eosinophil activities as part of studies of human disease in the mouse.
